← Insider buys
UTHR

United Therapeutics Corporation · Healthcare

EVP and General Counsel Paul A Mahon sold $610K of United Therapeutics Corporation

Sold$609,675
$243.87Price
2,500Shares
−6%Stake

What UTHR did after the filing

Filed Jul 24Copier in Jul 25
The stock from Tue, Jul 25 open, $243.91
−8.4%
S&P 500, same days
−1.7%

Measured over 30 trading days, to the Sep 6 close.

Traded Thu, Jul 20. Filed Mon, Jul 24, 4:30 PM ET, after the close. Returns use the Jul 25 open and the Sep 6 close. Not investment advice.